Physician Self Disclosure of IUC Use
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01994356 |
Recruitment Status :
Completed
First Posted : November 25, 2013
Last Update Posted : November 25, 2013
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Contraception | Behavioral: Physician self-disclosure of personal IUC use Behavioral: Usual contraceptive counseling | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 132 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | Single (Participant) |
Primary Purpose: | Treatment |
Official Title: | Pilot Study of Physician Self-disclosure of Personal Intrauterine Contraceptive Use Versus Usual Counseling |
Study Start Date : | January 2011 |
Actual Primary Completion Date : | February 2013 |
Actual Study Completion Date : | February 2013 |

Arm | Intervention/treatment |
---|---|
Active Comparator: Usual contraceptive counseling
subjects received usual contraceptive counseling
|
Behavioral: Usual contraceptive counseling
all subjects recieved usual contraceptive counseling
Other Name: contraceptive counseling |
Experimental: Physician self-disclosure of IUC use
subjects received usual contraceptive counseling plus intervention which was Physician self-disclosure of personal IUC use during the counseling
|
Behavioral: Physician self-disclosure of personal IUC use
Physicians self-disclosed personal intrauterine contraceptive use to subjects in intervention arm of study during contraceptive counseling |
- Intrauterine contraceptive use [ Time Frame: immediately following clinical encounter and at 2 months ]All subjects were surveyed to determine use of intrauterine contraceptive immediately after their clinical visit where contraceptive counseling was received and at 2 months after their clinical encounter to assess intrauterine contraceptive use.
- Satisfaction with clinical encounter [ Time Frame: immediately following clinical encounter and at 2 months ]All subjects were surveyed to determine their with satisfaction with their overall clinical encounter immediately following their clinical encounter at at 2 months. Satisfaction was measured using a 5 point scale.
- Satisfaction with contraceptive method [ Time Frame: immediately following clinical enocunter and at 2 months ]All subjects were surveyed to determine satisfaction with their contraceptive method of choice immediately following their clinical encounter and at 2 months. Satisfaction was measured using a 5 point scale.
- Satisfaction with provider [ Time Frame: immediately following clinical encounter and at 2 months ]All subjects were surveyed to determine satisfaction with their provider immediately following their clinical encounter and at 2 months. Satisfaction was measured using a 5 point scale.

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 44 Years (Adult) |
Sexes Eligible for Study: | Female |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- reproductive age
- currently sexually active
- scheduled for benign gynecology visit, annual exam, or family planning visit
Exclusion Criteria:
- seeking pregnancy within 1 year
- currently using IUC
- prior sterilization procedure
- currently pregnant

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01994356
United States, Michigan | |
University of Michigan Medical Center | |
Ann Arbor, Michigan, United States, 48109 |
Responsible Party: | Mya Zapata, Clinical Lecturer, University of Michigan |
ClinicalTrials.gov Identifier: | NCT01994356 |
Other Study ID Numbers: |
IUC Disclosure N014264 ( Other Grant/Funding Number: Sociey of Family Planning ) |
First Posted: | November 25, 2013 Key Record Dates |
Last Update Posted: | November 25, 2013 |
Last Verified: | November 2013 |
Contraceptive counseling Physician self disclosure Satisfaction Intrauterine contraceptive use |
Contraceptive Agents Reproductive Control Agents Physiological Effects of Drugs |